Detection of Escherichia coli O157:H7 and O104:H4 in patients with diarrhea in Northern Lebanon and characterization of fecal E.coli producing ESBL and carbapenemase genes

Prevalence and antibiotic susceptibility patterns of bacteria causing urinary tract infections in Youssef Hospital Center: first report from Akkar governorate, North of Lebanon

“…Moreover, we found that resistance to ertapenem, imipenem and meropenem was about 1.1%, 0.4% and 0.4%, respectively. Several recent studies reported the emergence carbapenem-resistance strains in North of Lebanon, mainly by OXA-48 production [25][26][27][28][29][30]. Gentamicin and ciprofloxacin resistance were about 19.9% and 38.3%, respectively, which are in the range of previous community based studies in Lebanon [8,15,18,25].…”

“…Several recent studies reported the emergence carbapenem-resistance strains in North of Lebanon, mainly by OXA-48 production [25][26][27][28][29][30]. Gentamicin and ciprofloxacin resistance were about 19.9% and 38.3%, respectively, which are in the range of previous community based studies in Lebanon [8,15,18,25]. Regarding to the other isolated Enterobacteriaceae, the resistance rate was lower than that observed in E. coli isolated isolates, except with Proteus spp.…”

“…Our findings showed similar percentages of resistance to antibiotics described in previous studies conducted in Lebanon. Numerous recent investigations found a high prevalence of ESBL-producing E. coli [8,15,25]. Moreover, we found that resistance to ertapenem, imipenem and meropenem was about 1.1%, 0.4% and 0.4%, respectively.…”

Prevalence and antibiotic susceptibility of ear pathogens isolated from patients in Tripoli, north of Lebanon

“…Various previous studies conducted in Lebanon showed a high prevalence of extended-spectrum beta-lactamases (ESBL)-producing E. coli with a mean rate of 20% [7,15] to 32% [5]. In addition, several reports described the emergence of carbapenemase-producing E. coli isolates, particularly OXA-48 [class D β-lactamases] [13,15,[27][28][29]. In the present study, ESBL-producing E. coli was in the range of the previous reports since ertapenem, imipenem and meropenem resistance rates were about 6%, 0% and 0%, respectively.…”

“…In Lebanon, numerous recent studies reported an increasing high rates of resistant bacteria isolates from clinical and commensal sources to most antimicrobials [5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21]. However, few data about the bacterial ear pathogens in Lebanon is available.…”